Abiomed Inc (ABMD) Return on Assets ROA from the second quarter of 2023 to second quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abiomed Inc   (NASDAQ: ABMD)


Abiomed Inc 's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Abiomed Inc 's ROA in the second quarter of 2023?
Abiomed Inc achieved a return on average assets (ROA) of 16.09 % in its second quarter of 2023, which is below Abiomed Inc 's average return on assets, which stands at 16.19%.

ROA has improved compared to 13.43% in the first quarter of 2023, due to net income growth.

However, within the Healthcare sector 59 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2022 quarter, so far to 439, from total ROA ranking in the first quarter of 2023 at 582.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter		 (Dec 31 2021)
III. Quarter		 (Sep 30 2021)
II. Quarter
Y / Y Total Assets Change 9.86 % 15.86 % 24.43 % 12.86 % 34.52 %
Y / Y Net Income Change 86.35 % - 6.1 % -26.05 % -8.45 %
Net Income (TTM) in million 267 218 137 133 149
Return On Assets (TTM) 16.09 % 13.43 % 8.74 % 8.99 % 10.39 %
ABMD's Total Ranking # 439 # 582 # 959 # 1094 # 771
Total Assets (TTM) in million 1,681 1,688 1,673 1,591 1,530
Seq. Total Assets Change -0.42 % 0.86 % 5.2 % 3.97 % 5.02 %
Seq. Net Income Change 94.55 % -9.57 % 31.85 % -19.67 % -

ABMD's 5 Years Annual ROA >> Back to ABMD Management Effectiveness >> Compare ABMD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 14
Sector # 60
Overall # 430

Return On Assets Statistics
High Average Low
45.44 %
16.19 %
3.36 %
(Mar 31 2015)   (Sep 30 2013)





Financial Statements
Abiomed Inc 's Assets $ 1,681 million ABMD's Balance sheet
Abiomed Inc 's Income $ 106 million Quarterly ABMD's Income Statement
ABMD's Income by Division See ABMD's Income by Division



Annual Return On Assets (Mar 31 2022)
FY 2022		 (Mar 31 2021)
FY 2021		 (Mar 31 2020)
FY 2020		 (Mar 31 2019)
FY 2019		 (Mar 31 2018)
FY 2018
Y / Y Total Assets Change 12.69 % 22.07 % 15.38 % 34.08 % 42.87 %
Total Assets in million 1,673 1,485 1,216 1,054 786
Y / Y Net Income Change -39.47 % 11.09 % -21.62 % 130.91 % 115.23 %
Net Income in million 137 226 203 259 112
Annual Return On Assets 8.16 % 15.19 % 16.69 % 24.57 % 14.26 %

ABMD's 5 Years Annual ROA >> Back to ABMD Management Effectiveness >> Compare ABMD ROA to its Competitors



Comment on ABMD's ROA in the fiscal year ending 2022
In the fiscal year 2022 Abiomed Inc 's ROA decreased compared to previous year to 8.16 %, due to deterioration of net income -39.47 % to $136.51 million, from $225.53 million a year ago, as ABMD's assets were $1,673.39 million.


More Return On Assets Ratios
ABMD's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ABMD's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ABMD's Competitors
Subscribers only: Roa for Abiomed Inc 's Suppliers
Subscribers only: Return On Assets for ABMD's Customers

You may also want to know
ABMD's Roi ABMD's Inventory Turnover Ratio ABMD's Growth Rates ABMD's Dividend Comparisons
ABMD's Profitability Ratios ABMD's Asset Turnover Ratio ABMD's Dividend Growth
ABMD's Roe ABMD's Valuation Ratios ABMD's Financial Strength Ratios ABMD's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector ROA
Intercept Pharmaceuticals inc   39.53 %
Vicarious Surgical Inc  34.58 %
Biofrontera Inc   34.40 %
Prophase Labs Inc   32.74 %
Dynavax Technologies Corporation  31.96 %
Iteos Therapeutics Inc   31.38 %
Ethema Health Corporation   30.79 %
Harmony Biosciences Holdings inc   30.44 %
Innoviva Inc   29.71 %
Exelixis Inc   29.31 %
Avid Bioservices Inc   29.05 %
Idexx Laboratories Inc  26.06 %
REST EZ Inc.  26.06 %
Oncotelic Therapeutics Inc   25.28 %
Orgenesis Inc   25.28 %
Maravai Lifesciences Holdings Inc   25.27 %
Mettler toledo International Inc   25.16 %
Cartesian Therapeutics Inc   24.84 %
Catalyst Pharmaceuticals Inc   24.67 %
Corcept Therapeutics Inc  24.31 %
Embecta Corp   24.11 %
Nrc Health  23.92 %
Dariohealth Corp   22.74 %
Waters Corporation  22.68 %
Gyre Therapeutics Inc   22.60 %
Semler Scientific inc   22.46 %
Shockwave Medical Inc   21.85 %
Vertex Pharmaceuticals Inc  21.83 %
Journey Medical Corp  21.14 %
Regeneron Pharmaceuticals Inc   20.14 %

Date modified: 2026-08-29T17:31:38+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.